Evidence map›Paper›PMID 41155485›Full record

ArticleInternational journal of molecular sciences2025

Enhancing Local Functional Structure Features to Improve Drug-Target Interaction Prediction.

Baoming Feng, Haofan Du, Henry H Y Tong, Xu Wang, Kefeng Li

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Baoming FengCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999708, China.ORCID 0009-0000-3704-1680
Haofan DuSchool of Physics and Technology, Nanjing Normal University, Nanjing 210023, China.
Henry H Y TongCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999708, China.ORCID 0000-0003-2687-741X
Xu WangState Key Laboratory of Food Nutrition and Safety, College of Food Science and Engineering, Tianjin University of Science and Technology, Tianjin 300457, China.ORCID 0000-0001-6301-3587
Kefeng LiCenter for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999708, China.ORCID 0000-0002-7233-4347

Funding

Macao Polytechnic University (RP/FCA-14/2023)Macau Science and Technology Development Fund and the Department of Science and Tech-nology of Guangdong Province (FDCT-GDST, 0009/2024/AGJ)
6 · The paper itself

Abstract

Molecular simulation is central to modern drug discovery but is often limited by high computational cost and the complexity of molecular interactions. Deep-learning drug-target interaction (DTI) prediction can accelerate screening; however, many models underuse the local functional structure features-binding motifs, reactive groups, and residue-level fragments-that drive recognition. We present LoF-DTI, a framework that explicitly represents and couples such local features. Drugs are converted from SMILES into molecular graphs and targets from sequences into feature representations. On the drug side, a Jumping Knowledge (JK) enhanced Graph Isomorphism Network (GIN) extracts atom- and neighborhood-level patterns; on the target side, residual CNN blocks with progressively enlarged receptive fields, augmented by N-mer substructural statistics, capture multi-scale local motifs. A Gated Cross-Attention (GCA) module then performs atom-to-residue interaction learning, highlighting decisive local pairs and providing token-level interpretability through attention scores. By prioritizing locality during both encoding and interaction, LoF-DTI delivers competitive results across multiple benchmarks and improves early retrieval relevant to virtual screening. Case analyses show that the model recovers known functional binding sites, suggesting strong potential to provide mechanism-aware guidance for molecular simulation and to streamline the drug design pipeline.

Indexed as

Drug DiscoveryBinding SitesDeep LearningHumansNeural Networks, ComputerPharmaceutical PreparationsPharmaceutical Preparationsattention mechanismdrug–target interactiongated cross-attentionlocal functional structuresmolecular simulationneural network

Identifiers

PMID41155485
PMCPMC12563810

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.